Dr. Stokke is a medical physicist by training, with a PhD in pharmacy. Over the last decade, she has worked with a wide range of different radiopharmaceuticals and been actively involved in both research activities and clinical implementation. Her research projects often focus on dosimetry and novel radiotherapeutics. Dr. Stokke has been head of the clinical nuclear medicine physics section at Oslo University Hospital, Norway, since 2013.

She established a new research group at the hospital in 2017, entitled “Theragnostic Imaging,” for which she is still the group leader.

Dr. Stokke is also an associate professor at the University of Oslo, where she established and is responsible for the MSc/PhD-level course “Medical Imaging with Ionising Radiation.” In addition to this, she is or has been involved in various other teaching activities, such as being responsible for several mandatory national courses in nuclear medicine. Over the last five years, she has organized or given presentations at several sessions at the annual EANM congress. Dr. Stokke has been on the EANM’s dosimetry committee since 2019 and is the chair of the committee from 2024. She is a member of the executive board of EURAMED (on behalf of EANM) and an associate editor for EJNMMI Physics. Other current responsibilities include being a board member of the Nordic Association for Clinical Physics and serving as president of the Norwegian Association for Medical Physics.

Latest Publications

• Can ¹⁷⁷Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data
• Rethinking Dosimetry: A European Perspective
• First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted ²¹²Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer
• The prognostic value of [¹⁸F]FDG PET/CT texture analysis prior to transplantation for unresectable colorectal liver metastases
• Do we need dosimetry for the optimization of theranostics in CNS tumors?

All publications